Prognostic significance of ultrasound myocardial tissue characterization in patients with cardiac amyloidosis

被引:55
|
作者
Koyama, J [1 ]
Ray-Sequin, PA [1 ]
Falk, RH [1 ]
机构
[1] Boston Med Ctr, Cardiol Sect, Boston, MA 02118 USA
关键词
amyloid; prognosis; echocardiography;
D O I
10.1161/01.CIR.0000023530.86718.B0
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background-Cycle-dependent variation of myocardial integrated backscatter (CV-IB) is an objective measurement that may detect myocardial abnormalities. However, no data exist about the prognostic v value of CV-IB in primary cardiac amyloidosis. Methods and Results-We prospectively examined 208 consecutive biopsy-proven patients with primary amyloidosis. The magnitude of CV-IB was analyzed at the interventricular septum and left ventricular (LV) posterior wall and its prognostic value was compared with standard Doppler measurements with to the Tei index (isovolumic contraction time plus isovolumic relaxation time divided by ejection time). One hundred thirty-three patients had cardiac involvement (mean LV thickness >12 mm). Forty-one patients (20%) (32 cardiac deaths) died during a mean follow-up of period of 307+/-156 days. Univariate analysis showed that the CV-IB at the LV posterior wall was the best predictor of-cardiac death (P<0.0001) and all-cause death (P<0.0001). The Tei index did not identify patients at risk of death. Multivariate analysis showed that CV-IB at the LV posterior wall was the only independent predictor of both cardiac and overall deaths. Conclusions-Among patients with cardiac amyloidosis, CV-IB at the LV posterior wall is a powerful predictor of clinical outcome and is superior to standard echocardiographie/Doppler flow indexes.
引用
收藏
页码:556 / 561
页数:6
相关论文
共 50 条
  • [31] Prognostic impact of hypertension and diabetes in patients with cardiac amyloidosis
    Argiro, Alessia
    Biagioni, Giulia
    Mazzoni, Carlotta
    Zampieri, Mattia
    Allinovi, Marco
    Musumeci, Beatrice
    Tini, Giacomo
    Cianca, Alessandro
    Merlo, Marco
    Sinagra, Gianfranco
    Porcari, Aldostefano
    Pozzan, Marco
    Canepa, Marco
    Zanoletti, Margherita
    Labate, Marianna Eleonora
    Ponziani, Alberto
    Saturi, Giulia
    Ruotolo, Irene
    Longhi, Simone
    Biagini, Elena
    Perfetto, Federico
    Cappelli, Francesco
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2025, 424
  • [32] Clinical significance of quantitative bone SPECT measurement for left ventricular myocardial deformation in patients with cardiac amyloidosis
    Fukushima, Kenji
    Yamane, Tomohiko
    Matsusaka, Yohji
    Seto, Akira
    Egi, Ryuta
    Oyama-Suzuki, Kyoko
    Okano, Nanami
    Sugi, Keiki
    Nakano, Shintaro
    Muramatsu, Toshihiro
    Matsunari, Ichiro
    Kuji, Ichiei
    JOURNAL OF NUCLEAR MEDICINE, 2021, 62
  • [33] Prognostic value of cardiac biomarkers in patients with transthyretin deposition cardiac amyloidosis
    De Sanmamed Giron, M. Miguel Fernandez
    Galvan Ruiz, M.
    Singh, M.
    Lopez Perez, M.
    Groba Marco, M.
    Pena Ortega, P.
    Rua-Figueroa Erausquin, D.
    Suarez Perez, I.
    Blanco Nuez, M.
    Cardenes Leon, A.
    Mendoza Lemes, H.
    Quevedo Nelson, V.
    Martin Lorenzo, P.
    Caballero Dorta, E.
    Garcia Quintana, A.
    EUROPEAN JOURNAL OF HEART FAILURE, 2021, 23 : 99 - 99
  • [34] RAREFACTION OF MYOCARDIAL LYMPHATIC VESSELS IN PATIENTS WITH CARDIAC AMYLOIDOSIS
    Aimo, A.
    Martinelli, G.
    Bonino, L.
    Musetti, V.
    Castiglione, V.
    Emdin, M.
    Vergaro, G.
    Pucci, A.
    EUROPEAN HEART JOURNAL SUPPLEMENTS, 2023, 25 : D26 - D26
  • [35] Myocardial Oxygen Consumption and Efficiency in Patients With Cardiac Amyloidosis
    Clemmensen, Tor Skibsted
    Soerensen, Jens
    Hansson, Nils Henrik
    Tolbod, Lars Poulsen
    Harms, Hendrik J.
    Eiskjaer, Hans
    Mikkelsen, Fabian
    Wiggers, Henrik
    Andersen, Niels Frost
    Poulsen, Steen Hvitfeldt
    JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2018, 7 (21):
  • [36] RAREFACTION OF MYOCARDIAL LYMPHATIC VESSELS IN PATIENTS WITH CARDIAC AMYLOIDOSIS
    Aimo, Alberto
    Martinelli, Giulia
    Bonino, Lucrezia
    Musetti, Veronica
    Emdin, Michele
    Pucci, Angela
    EUROPEAN HEART JOURNAL SUPPLEMENTS, 2022, 24
  • [37] Rarefaction of myocardial lymphatic vessels in patients with cardiac amyloidosis
    Aimo, A. Alberto
    Martinelli, G.
    Bonino, L.
    Castiglione, V.
    Musetti, V.
    Passino, C.
    Vergaro, G.
    Pucci, A.
    EUROPEAN JOURNAL OF HEART FAILURE, 2023, 25 : 371 - 372
  • [38] The prognostic significance of Weber and ventilatory CPET classifications in amyloidosis patients
    Patarroyo, S. Santos
    Ortega-Aviles, L.
    Grogan, M.
    Allison, T.
    EUROPEAN HEART JOURNAL, 2024, 45
  • [39] Prognostic significance of interventricular septal thickness in patients with AL amyloidosis
    Cho, Hyunsoo
    Kim, Soo-Jeong
    Shim, Chi Young
    Hong, Geu-Ru
    Ha, Jong-Won
    Kim, Yu Ri
    Yang, Woo Ick
    Chung, Haerim
    Jang, Ji Eun
    Cheong, June-Won
    Min, Yoo Hong
    Kim, Jin Seok
    LEUKEMIA RESEARCH, 2017, 60 : 36 - 43
  • [40] Prognostic significance of right ventricular dysfunction in patients with TTR amyloidosis
    Istratoaie, S.
    Al Wazzan, A.
    Antonelli, J.
    Oger, E.
    Donal, E.
    EUROPEAN HEART JOURNAL, 2024, 45